+91 9027860789
Welcome To A Corporate World, Register Your Start Up As A Company | Raising Funds For The Expansion Of Business | Core Due Diligence Of All Types Of Companies | Secretarial Audits | Maintenance Of Minutes And Other Secretarial/Statutory Records | Make Your Board Meetings And General Meeting Convenient And Easy | All Secretarial Services With Respect To Company Laws | Corporate Restructuring (Merger & Amalgamation, Demerger, Acquisition, Dissolution & Winding Up Etc.) | Corporatization Of Businesses | The Insolvency And Bankruptcy Services For The Companies | The Insolvency And Bankruptcy Services For The Companies | Services Under Limited Liability Partnership Firms | Services Under Foreign Contribution Regulation Act
office@camadhuraggarwal.com

Stem Cell Banking Declared Health Care Service: SC Grants Relief

Supreme Court: Stem Cell Banking Qualifies as Health Care Service, Exempt from Service Tax

In a major relief to the medical services sector, the Supreme Court of India has ruled that stem cell banking—including the enrolment, collection, testing, processing, and storage of umbilical cord blood stem cells—qualifies as a “health care service” under the Finance Act, 1994. As a result, such services are exempt from service tax for the relevant period.

This judgment overturns the earlier ruling of the Customs, Excise and Service Tax Appellate Tribunal (CESTAT), Ahmedabad, which had upheld service tax demands against Stemcyte India, a stem cell banking company.


Case Background

The dispute centered on service tax demands imposed on Stemcyte India for the period between July 1, 2012, and February 16, 2014. The Revenue Department claimed that stem cell banking was not listed under tax-exempt health care services before the introduction of Entry 2A in February 2014 through an amendment.

The department argued that the 2014 exemption notification applied only prospectively, and therefore, services offered before that date were taxable. They also imposed interest and penalties, alleging suppression of facts and intent to evade tax.


Stemcyte’s Argument

The company countered this claim, stating that:


Supreme Court’s Key Findings

In its detailed judgment, the Supreme Court made several important observations:

1. Stem Cell Banking is Part of Health Care

The Court held that stem cell banking plays a preventive and therapeutic role, especially for future treatment of serious illnesses such as cancers, immune disorders, and blood-related diseases. Therefore, it squarely falls within the definition of “health care services” under the Finance Act.

2. Broad Interpretation of Exemptions

Referring to Notification No. 25/2012-ST dated 20 June 2012, the Court emphasized that health care services should not be interpreted narrowly. Services that contribute to diagnosis, treatment, or care—even if preventive in nature—must be considered exempt.

3. 2014 Notification is Clarificatory

The 2014 introduction of Entry 2A, which explicitly mentioned stem cell services, was held to be clarificatory, not a new exemption. The Court ruled that such clarification should be applied in ongoing or pending cases, even though the notification itself did not expressly state retrospective application.

4. No Intent to Evade Tax

The Court noted that Stemcyte had not acted with intent to evade tax. The company had maintained transparent records and had sought clarity from the authorities, weakening the case for extended limitation and penalty imposition.


Industry Impact

This verdict has far-reaching implications for the stem cell banking sector, which has long faced ambiguity regarding tax treatment. The ruling:

It also reinforces the judiciary’s approach of interpreting tax exemption notifications liberally and purposively, especially in matters related to public health.


Conclusion

The Supreme Court’s ruling is a landmark decision for India’s growing biomedical and health-tech industries. It acknowledges that modern medical practices like stem cell banking are an essential part of today’s health care ecosystem.

By recognizing the preventive and therapeutic value of stem cell preservation, the Court has provided much-needed legal clarity and reaffirmed its support for accessible, forward-looking healthcare services.

📅 Published on: 15 July 2025
✍️ Author: CS Chhavi Goyal